Literature DB >> 10775035

Lung-targeted expression of the c-Raf-1 kinase in transgenic mice exposes a novel oncogenic character of the wild-type protein.

E Kerkhoff1, L M Fedorov, R Siefken, A O Walter, T Papadopoulos, U R Rapp.   

Abstract

The c-Raf-1 kinase is a downstream effector of Ras signaling. Both proteins are highly oncogenic when they are mutationally activated, but only the Ras GTPase is frequently mutated in naturally occurring tumors. Although the c-Raf-1 protein was found to be amplified in different lung cancer cell lines, overexpression of the wild-type c-Raf-1 protein was shown to be insufficient to transform cultured cells. Here we have addressed the question of whether overexpression of the wild-type c-Raf-1 kinase can induce lung cancer in mice. We show that lung-targeted expression of oncogenically activated or wild-type c-Raf-1 proteins induces morphologically indistinguishable lung adenomas in transgenic mice. Compared with mice transgenic for the activated c-Raf-1-BxB, tumor development is delayed and occurs at a lower incidence in wild-type c-Raf-1 transgenic mice. Our studies show that the c-Raf-1 expression level is a critical parameter in tumor development and should be analyzed in more detail to evaluate its potential in the induction of cancer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10775035

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  35 in total

1.  Genetic variations in multiple drug action pathways and survival in advanced stage non-small cell lung cancer treated with chemotherapy.

Authors:  Yafei Li; Zhifu Sun; Julie M Cunningham; Marie C Aubry; Jason A Wampfler; Gary A Croghan; Cassandra Johnson; Danli Wu; Jeremiah A Aakre; Julian Molina; Liewei Wang; V Shane Pankratz; Ping Yang
Journal:  Clin Cancer Res       Date:  2011-06-01       Impact factor: 12.531

Review 2.  Selective Raf inhibition in cancer therapy.

Authors:  Vladimir Khazak; Igor Astsaturov; Ilya G Serebriiskii; Erica A Golemis
Journal:  Expert Opin Ther Targets       Date:  2007-12       Impact factor: 6.902

Review 3.  Mouse models for BRAF-induced cancers.

Authors:  C Pritchard; L Carragher; V Aldridge; S Giblett; H Jin; C Foster; C Andreadi; T Kamata
Journal:  Biochem Soc Trans       Date:  2007-11       Impact factor: 5.407

4.  STAT3-enhancing germline mutations contribute to tumor-extrinsic immune evasion.

Authors:  Daniel Kogan; Alexander Grabner; Christopher Yanucil; Christian Faul; Vijay Kumar Ulaganathan
Journal:  J Clin Invest       Date:  2018-04-03       Impact factor: 14.808

5.  Conditional expression of oncogenic C-RAF in mouse pulmonary epithelial cells reveals differential tumorigenesis and induction of autophagy leading to tumor regression.

Authors:  Fatih Ceteci; Jiajia Xu; Semra Ceteci; Emanuele Zanucco; Chitra Thakur; Ulf R Rapp
Journal:  Neoplasia       Date:  2011-11       Impact factor: 5.715

6.  Elimination of B-RAF in oncogenic C-RAF-expressing alveolar epithelial type II cells reduces MAPK signal intensity and lung tumor growth.

Authors:  Emanuele Zanucco; Nefertiti El-Nikhely; Rudolf Götz; Katharina Weidmann; Verena Pfeiffer; Rajkumar Savai; Werner Seeger; Axel Ullrich; Ulf R Rapp
Journal:  J Biol Chem       Date:  2014-08-05       Impact factor: 5.157

7.  The mitotic kinase Aurora--a promotes distant metastases by inducing epithelial-to-mesenchymal transition in ERα(+) breast cancer cells.

Authors:  A B D'Assoro; T Liu; C Quatraro; A Amato; M Opyrchal; A Leontovich; Y Ikeda; S Ohmine; W Lingle; V Suman; J Ecsedy; I Iankov; A Di Leonardo; J Ayers-Inglers; A Degnim; D Billadeau; J McCubrey; J Ingle; J L Salisbury; E Galanis
Journal:  Oncogene       Date:  2013-01-21       Impact factor: 9.867

Review 8.  Modelling oncogenic Ras/Raf signalling in the mouse.

Authors:  Florian A Karreth; David A Tuveson
Journal:  Curr Opin Genet Dev       Date:  2009-02-07       Impact factor: 5.578

9.  MYC is a metastasis gene for non-small-cell lung cancer.

Authors:  Ulf R Rapp; Christian Korn; Fatih Ceteci; Christiaan Karreman; Katharina Luetkenhaus; Valentina Serafin; Emanuele Zanucco; Inês Castro; Tamara Potapenko
Journal:  PLoS One       Date:  2009-06-24       Impact factor: 3.240

10.  Cancer genomics identifies regulatory gene networks associated with the transition from dysplasia to advanced lung adenocarcinomas induced by c-Raf-1.

Authors:  Astrid Rohrbeck; Jürgen Borlak
Journal:  PLoS One       Date:  2009-10-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.